Positron emission tomographic studies of aging and Alzheimer disease.

TitlePositron emission tomographic studies of aging and Alzheimer disease.
Publication TypeJournal Article
Year of Publication1983
Authorsde Leon MJ, Ferris SH, George AE, Christman DR, Fowler JS, Gentes C, Reisberg B, Gee B, Emmerich M, Yonekura Y, Brodie J, Kricheff II, Wolf AP
JournalAJNR Am J Neuroradiol
Volume4
Issue3
Pagination568-71
Date Published1983 May-Jun
ISSN0195-6108
KeywordsAdult, Aged, Aging, Alzheimer Disease, Blood Glucose, Dementia, Deoxyglucose, Fluorodeoxyglucose F18, Humans, Middle Aged, Tomography, Emission-Computed
Abstract

In this study the positron emission tomographic (PET)-18F-2-deoxy-2-fluoro-D-glucose (FDG) technique was used to study both normal aging and senile dementia. The results derived from 15 young normal subjects (mean age, 26 +/- 5 years) and 22 elderly normal subjects (mean age, 66 +/- 7 years) failed to indicate significant metabolic changes associated with age. A group of 24 patients with senile dementia (mean age, 73 +/- 7 years) showed consistent diminutions in regional glucose use relative to the elderly normals. Across all brain regions the diminutions were 17%-24%. There were also significant correlations between the measures of glucose use and the measures of cognitive functioning. Discriminant function classification analysis results indicate that better than 80% classification accuracy can be achieved for individual PET measures. These data suggest a possible future diagnostic use of PET in senile dementia.

Alternate JournalAJNR Am J Neuroradiol
PubMed ID6410799
PubMed Central IDPMC8334899
Grant ListMH 36969-01 / MH / NIMH NIH HHS / United States
NS 15638 / NS / NINDS NIH HHS / United States
Related Institute: 
Brain Health Imaging Institute (BHII)

Weill Cornell Medicine
Department of Radiology
525 East 68th Street New York, NY 10065